Scribe Therapeutics

Scribe is rewriting medicine with molecular engineering, focusing on creating safe and effective genetic medicines using CRISPR technology to treat cardiometabolic diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Scribe is rewriting medicine with molecular engineering, focusing on creating safe and effective genetic medicines using CRISPR technology to treat cardiometabolic diseases.

02Backed By1 investor

RCRA Capital Management→

03Similar Companies